FINWIRES · TerminalLIVE
FINWIRES

Evolution Mining Shows Ability to Translate Gold Fundamentals to Cash Generation, Jefferies Says

By

Evolution Mining (ASX:EVN) exhibited a potent ability to translate current gold fundamentals through to cash generation even as it posted a resounding miss to fiscal third-quarter metrics, Jefferies said in a Thursday note.

The company's operational issues in the quarter were temporary and it has a better cash flow outlook for the fiscal fourth quarter, while increasing optics on capital management are outweighing a softer fiscal 2027 outlook, the equity research firm said.

Although lower Cowal mine volumes and higher all-in sustaining costs represent headwinds, the transition to processing low-grade stockpiles should support lower cash costs and help sustain operating mine cash flow.

Jefferies added that Evolution Mining's balance sheet is in good order, and its liquidity position of roughly AU$1.90 billion, with no debt repayments due until fiscal 2029, give it plenty of flexibility to finance growth initiatives.

"We continue to see upside risk to [capital expenditure] beyond FY26, with the stronger balance sheet supporting concurrent project funding rather than prior sequencing, while [Evolution Mining's] stated ambition to manage up to eight assets leaves M&A an option," Jefferies said.

It maintained an underperform rating and AU$11 price target on the company.

Evolution Mining's shares fell almost 4% in recent Friday trade.

Related Articles

Asia

Netwealth's FUA Net Flows in Fiscal Q4 Likely to See Seasonal Step-up, Jarden Says

Netwealth Group's (ASX:NWL) funds under administration (FUA) net flows are likely to see a seasonal step-up in the fiscal fourth quarter, which would see the fiscal 2026 outcome tracking slightly ahead of its guidance range, Jarden said in a Thursday note.It raised its earnings-per-share forecasts by 0.1% for fiscal 2026, 1.5% for fiscal 2027, and 1.6% for fiscal 2028.Jarden also flagged the risk of higher cost growth due to the enforceable undertaking, regulatory scrutiny, and recent treasury consultations.The investment firm retained its neutral recommendation on Netwealth Group and raised the price target to AU$25.70 from AU$25.35.Netwealth Group's shares gained 1% in recent Friday trade.

ASX:NWL
Asia

CDL Hospitality REIT Issues Stapled Securities as Payment of Management Fee

CDL Hospitality REIT (SGX:J85) issued 5.5 million stapled securities to its manager, H-REIT Manager and HBT Trustee-Manager as payment of management fee for 2025, according to a Friday filing with the Singapore Exchange.Nearly 5 million stapled securities were issued to the H-REIT Manager at SG$0.8199 per security as 80% payment of its performance fee for 2025.Meanwhile, 535,179 securities were issued to HBT Trustee-Manager at SG$0.8199 per security as payment of 80% of performance fee for 2025.

SGX:J85
Asia

Syntara's Myelofibrosis Drug Candidate Shows 'Significant' Commercial Potential, Euroz Hartleys Says

Syntara's (ASX:SNT) Amsulostat drug candidate has a "unique" position in the myelofibrosis landscape and "significant" commercial potential, Euroz Hartleys said in a Thursday note.Myelofibrosis is a blood cancer characterized by scar tissue formation or fibrosis in the bone marrow.Dr Adam Craig, Syntara strategic adviser and an industry leader in myelofibrosis, noted Amsulostat's mechanism targeting fibrosis, with the potential as a disease-modifying therapy, rather than just a symptomatic treatment.Craig said that Amsulostat's safety profile differs from current therapies and is unaware of any other drug taking a similar approach.Additionally, Craig said that Amsulostat's mechanism requires time for effect, as fibrosis evolves gradually. Patient responses observed at six months are complemented by a continuing improvement over time.Euroz Hartleys reaffirmed its speculative buy recommendation and AU$0.22 price target on Syntara.Syntara shares fell 1% in afternoon trade on Friday.

ASX:SNT